KALV Bathi mangsa ngarep KalVista Pharma

KalVista Pharmaceuticals Inc - logo grafis emiten KALV

KalVista Pharmaceuticals (KALV) is actively collaborating with specialists in rare pathologies to refine its therapy. Anticipation of late-stage clinical trial results will serve as a key trigger, while R&D expenses are already priced in. The financial performance forecast on GURU.Markets is available for analysis, where the value of 0.04 shows the latest figure. The company's revenues will be based on the commercialization of oral treatments for hereditary angioedema.

KALV: Prakiraan bathi perusahaan KalVista Pharmaceuticals 05.09.2025 - 21.06.2026

Rincian analitis perusahaan KalVista Pharmaceuticals

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:KALV, KalVista Pharmaceuticals Inc
Barang utama KalVista Corp

The development of sebetralstat for HAE therapy by KalVista Pharmaceuticals (KALV) creates the potential for a radical shift in treatment, converting FDA approval expectations into actual cash flows. This metric aggregates analyst consensus net profit forecasts, stripping speculation from the valuation, which allows for the determination of the asset's fair value and the risk of overpaying for future success via target profit indicators on GURU.Markets.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Prakiraan bathi resik ZBIO (Zenas Biopharma, Inc.)|Bathi mangsa ngarep IMNM (Immunome Bio)|Prakiraan bathi perusahaan Gossamer Bio, Inc.|Proyeksi bathi mangsa ngarep SEPN (Septerna Pharma)|Prakiraan bathi perusahaan Pieris Pharma (PVLA)|Savara Inc - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake RIGL (Rigel Corp)|anaptysbio.com (ANAB) - Bathi sing dikarepake|Astria Therapeutics, Inc. - Penghasilan resik sing dikarepake|ENGN (enGene) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake RAPT Therapeutics Inc. RAPT|Bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Bathi resik mangsa ngarep ACRS|Proyeksi bathi mangsa ngarep KYTX (Kyverna Therapeutics)|Prakiraan bathi perusahaan Tiziana Life Sciences (TLSA)|Cabaletta Bio - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Ventyx Biosciences, Inc. VTYX|Theratechnologies Inc (THTX) - Bathi sing dikarepake|Bathi forward AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep agenusbio.com|Proyeksi bathi mangsa ngarep CLYM|Bathi resik mangsa ngarep ZURA|Proyeksi bathi mangsa ngarep ATYR (aTyr Pharmaceuticals)|Penghasilan resik sing dikarepake ADAG|ImageneBio Inc - Proyeksi bathi mangsa ngarep|STTK (shattucklabs.com) - Prakiraan bathi resik|EQ: Proyeksi bathi mangsa ngarep|Connect Biopharma Holdings (CNTB) - Proyeksi bathi mangsa ngarep|IMUX (immunic-therapeutics.com) - Proyeksi bathi mangsa ngarep|ATRA (Atara Biotherapeutics) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep IFRX|Proyeksi bathi mangsa ngarep X4 Pharmaceuticals, Inc (XFOR)|Proyeksi bathi mangsa ngarep ACET (Adicet Bio Inc.)|CELU (Celularity Corp) - Bathi forward|INmune Bio Corp - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep